Theme watch · maturing
Medtech stocks to watch · September 2026.
As of 20 September 2026
Bionano Genomics’ clinical-adoption and reimbursement story supports a test of the $2.13 annual high. A daily close above that level would confirm…
Legacy hereditary-cancer testing house executing a diagnostics pivot; shares +40% off the June $3.99 base as Prolaris+AI launched (May 26) and…
Tempus AI's proposed Personalis acquisition supports a cancer-vaccine sequencing recovery thesis. A daily close above the August 21 reference…
Busted-growth genomics name; the recovery off the −49% May guide-cut crash has stalled in the low-$60s, below the $74.83 200-day. The confirmed…
AtriCure’s profitability and clinical-expansion story now has to sustain its re-rating after September 21 index inclusion. A weekly close at or…
Revvity’s AI drug-discovery story requires instrument backlog to convert into positive Life Sciences organic growth. The next quarterly report…
Inspire Medical Systems' rally prices a recovery from reimbursement disruption. A weekly close at or above Stifel's September 11, 2026 target of…
"3-mo price move" is the stock's market price change, not a FrontierPicks return. The "3-mo price move" column is one of the three inputs to that score, weighted 20% — not the ranking itself, so rows do not descend in it. A dash means the name did not place in this week’s top-50 momentum scan, so it has no published 3-month figure.
How this page is built
These are the names FrontierPicks covers in the medtech stocks cluster — each with a dated research dossier. Names on the momentum board rank first by a composite momentum score — 1-month price trend 50%, 3-month trend 20% and acceleration 30% — computed arithmetically from daily closes, then the rest of the covered roster by conviction tier. Cluster membership is assigned by a frontier model, currently read as maturing.
Questions
- What medtech stocks does FrontierPicks cover?
- As of 20 September 2026, the medtech stocks FrontierPicks tracks are led by BNGO, MYGN, TEM, WGS, each with a dated research dossier. Names on the momentum board rank first by composite momentum score, then the rest of the covered roster by conviction tier; this is research, not a recommendation.
- Is the medtech stocks theme accelerating or slowing?
- The FrontierPicks model reads this cluster as maturing as of 20 September 2026. Medical-device and diagnostic shares combine positive monthly returns with mixed company-specific attention: Bionano Genomics (BNGO) received September 15 surge coverage, while Tempus AI (TEM) received September 18 coverage of a decline. The narrative is provisionally maturing from last week's saturated classification, supported by measured gains of +42.3% over one month for Bionano, +24.7% for Inspire Medical Systems (INSP) and +24.5% for AtriCure (ATRC), although the headlines do not establish a shared reimbursement or adoption catalyst.
- How does FrontierPicks rank medtech stocks?
- Every name links to its dated research dossier. Names on the momentum board rank first by composite momentum score, then the rest of the covered roster by conviction tier. Methodology is open; this is research, not advice.
Related
As of 20 September 2026 · research, not advice.